These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4790625)
1. BL-20803, a new, low-molecular-weight interferon inducer. Siminoff P; Bernard AM; Hursky VS; Price KE Antimicrob Agents Chemother; 1973 Jun; 3(6):742-3. PubMed ID: 4790625 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro stimulation of mouse spleen leukocytes by BL-20803, a low-molecular-weight interferon inducer. Siminoff P Infect Immun; 1975 Nov; 12(5):1051-7. PubMed ID: 1193723 [TBL] [Abstract][Full Text] [Related]
3. [A new interferon inducer active via peroral administration]. Ershov FI; Saĭitkulov AM; Tazulakhova EB; Sadykov AS Vopr Virusol; 1986; 31(3):335-8. PubMed ID: 2429451 [TBL] [Abstract][Full Text] [Related]
4. Studies with low molecular weight inducers of interferon in man. Niblack JF Tex Rep Biol Med; 1977; 35():528-34. PubMed ID: 211671 [No Abstract] [Full Text] [Related]
5. [Study of the antiviral action of a new low-molecular interferon inducer]. Shcherbakova EG; Furer NM; Rastunova GA; Litvinov AN; Zhigachev VE Antibiotiki; 1976 Sep; 21(9):838-42. PubMed ID: 187112 [No Abstract] [Full Text] [Related]
6. Stimulation of interferon production in mice and in mouse spleen leukocytes by analogues of BL-20803. Siminoff P; Crenshaw RR Antimicrob Agents Chemother; 1977 Mar; 11(3):571-3. PubMed ID: 856006 [TBL] [Abstract][Full Text] [Related]
7. Interferon inducing activities of derivatives of 1,3-dimethyl-4-(3-dimethylaminopropylamino)-1H-pyrazolo(3,4-b)quinoline and related compounds. Crenshaw RR; Luke GM; Siminoff P J Med Chem; 1976 Feb; 19(2):262-75. PubMed ID: 1249806 [TBL] [Abstract][Full Text] [Related]
8. Target cells for interferon induction by BL-20803. Siminoff P J Infect Dis; 1976 Jun; 133 Suppl():A37-42. PubMed ID: 932505 [TBL] [Abstract][Full Text] [Related]
9. [Dynamics of interferon induction in albino mice by interferon inducer ridostin administered by various routes]. Bulychev LE; Goncharova EP; Ryzhikov AB; Masycheva VI; P'iankova OG; Pliasunov IV; Poryvaev VD; Kotliarov LA; Kolesnikova NG Antibiot Khimioter; 1998; 43(4):20-3. PubMed ID: 9606500 [TBL] [Abstract][Full Text] [Related]
10. Opposing effects of the interferon inducer, avridine: enhancement or suppression of tumor growth depending on treatment regimen. Talcott PA; Koller LD; Woodard LF; Whitbeck GA Int J Immunopharmacol; 1986; 8(6):553-9. PubMed ID: 2432025 [TBL] [Abstract][Full Text] [Related]